Psychological and Psychiatric Aspects of Treatment of Obesity and Nonalcoholic Fatty Liver Disease
Department of Psychiatry, Virginia Commonwealth University, Richmond, 23298-0268, USA.Clinics in liver disease (Impact Factor: 3.66). 08/2012; 16(3):615-29. DOI: 10.1016/j.cld.2012.05.007
Chronic illnesses incur a tremendous cost to American lives in dollars and quality of life. Outcomes in these illnesses are often affected by psychological, behavioral, and pharmacologic issues related to mental illness and psychological symptoms. This article focuses on psychological and psychiatric issues related to the treatment of obesity and nonalcoholic fatty liver disease (NAFLD), including available weight-loss interventions, the complex relationship between psychiatric disorders and obesity, and special considerations regarding use of psychiatric drugs in patients with or at risk for NAFLD and obesity. Recommendations for collaborative care of individuals with comorbid NAFLD and psychological disorders/symptoms are discussed.
- Clinical Pediatrics 01/2014; 53(14). DOI:10.1177/0009922813520072 · 1.15 Impact Factor
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed. The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual current impact factor. Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence agreement may be applicable.